Medpace
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $536,589 | $533,317 | $528,104 | $511,044 |
Gross Profit | 178,317 | 169,008 | 146,603 | 155,142 |
EBITDA | 125,378 | 126,294 | 112,385 | 111,061 |
EBIT | 118,776 | 105,150 | 104,069 | |
Net Income | 117,018 | 96,426 | 88,351 | 102,546 |
Net Change In Cash | 536,589 | 533,317 | 528,104 | 511,044 |
Free Cash Flow | 183,023 | 138,538 | 103,526 | 147,180 |
Cash | 669,436 | 656,900 | 510,894 | 407,010 |
Basic Shares | 31,873 | 32,088 | 32,086 | 32,001 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $2,109,054 | $1,885,842 | $1,459,996 | $1,142,377 |
Gross Profit | 656,305 | 524,505 | 432,438 | 328,155 |
EBITDA | 446,870 | 363,153 | 301,038 | 219,734 |
EBIT | 336,825 | 260,682 | 182,327 | |
Net Income | 404,386 | 282,810 | 245,211 | 181,390 |
Net Change In Cash | 2,109,054 | 1,885,842 | 1,459,996 | 1,142,377 |
Cost of Revenue | -426,467 | 187,510 | ||
Free Cash Flow | 608,815 | 396,726 | 351,171 | 235,056 |
Cash | 669,436 | 245,449 | 28,265 | 461,304 |
Basic Shares | 32,014 | 31,841 | 33,671 | 37,697 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | $3.68 |
2024-09-30 | $3.01 |
2024-06-30 | $2.75 |
2024-03-31 | $3.20 |
